ONCY · Company research
Oncolytics Biotech, Inc. Common Shares (ONCY): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Oncolytics Biotech Inc (ONCY) Stock Price Target & Forecast - TradingKey | Oncolytics Biotech Inc (ONCY) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Oct 15, 2026 | neutral | 0 | 0.6 |
| Oncolytics Biotech (NASDAQ:ONCY) Stock Price Up 9.8% - Here's Why - MarketBeat | Oncolytics Biotech (NASDAQ:ONCY) Stock Price Up 9.8% - Here's Why MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Patent protection for Oncolytics’ cancer therapy could extend into the late 2040s. - Stock Titan | Patent protection for Oncolytics’ cancer therapy could extend into the late 2040s. Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study - Stocktwits | ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Lab data show an experimental treatment increased immune cells in liver tumors. - Stock Titan | Lab data show an experimental treatment increased immune cells in liver tumors. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| ONCY Technical Analysis & Stock Price Forecast - Intellectia AI | ONCY Technical Analysis & Stock Price Forecast Intellectia AI | View source ↗ | Intellectia AI | Sep 25, 2026 | neutral | 0 | 0.6 |
| Oncolytics Biotech (NASDAQ:ONCY) Trading Down 5.2% - Time to Sell? - MarketBeat | Oncolytics Biotech (NASDAQ:ONCY) Trading Down 5.2% - Time to Sell? MarketBeat | View source ↗ | MarketBeat | Sep 23, 2026 | neutral | 0 | 0.6 |
| 3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets - Simply Wall Street | 3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets Simply Wall Street | View source ↗ | Simply Wall Street | Sep 16, 2026 | neutral | 0 | 0.6 |
| Oncolytics may seek accelerated approval using tumor response data - Stock Titan | Oncolytics may seek accelerated approval using tumor response data Stock Titan | View source ↗ | Stock Titan | Aug 18, 2026 | neutral | 0 | 0.6 |
| Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY) - Yahoo Finance | Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY) Yahoo Finance | View source ↗ | Yahoo Finance | Jul 13, 2026 | neutral | 0 | 0.6 |
| ONCY Forecast — Price Target — Prediction for 2027 - TradingView | ONCY Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| ONCY Stock Surged Today – Here’s What Securing A Key Immunotherapy Patent Means For Oncolytics - Yahoo Finance | ONCY Stock Surged Today – Here’s What Securing A Key Immunotherapy Patent Means For Oncolytics Yahoo Finance | View source ↗ | Yahoo Finance | Jun 16, 2026 | neutral | 0 | 0.6 |
| Oncolytics Biotech (ONCY) Valuation Check As New Pelareorep RAS Combo Data Draws Investor Attention - Yahoo Finance | Oncolytics Biotech (ONCY) Valuation Check As New Pelareorep RAS Combo Data Draws Investor Attention Yahoo Finance | View source ↗ | Yahoo Finance | Jun 3, 2026 | neutral | 0 | 0.6 |
| $ONCY stock is up 13% today. Here's what we see in our data. - Quiver Quantitative | $ONCY stock is up 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | May 29, 2026 | neutral | 0 | 0.6 |
| Oncolytics Says Colorectal Cancer Drug Outperforms Benchmarks - Oncolytics Biotech (NASDAQ:ONCY) - Benzinga | Oncolytics Says Colorectal Cancer Drug Outperforms Benchmarks - Oncolytics Biotech (NASDAQ:ONCY) Benzinga | View source ↗ | Benzinga | May 4, 2026 | neutral | 0 | 0.6 |
| $ONCY stock is down 10% today. Here's what we see in our data. - Quiver Quantitative | $ONCY stock is down 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.